Joseph Eckman

448 total citations
19 papers, 382 citations indexed

About

Joseph Eckman is a scholar working on Organic Chemistry, Molecular Biology and Physiology. According to data from OpenAlex, Joseph Eckman has authored 19 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 8 papers in Molecular Biology and 7 papers in Physiology. Recurrent topics in Joseph Eckman's work include Asthma and respiratory diseases (7 papers), Allergic Rhinitis and Sensitization (4 papers) and Synthesis and Biological Evaluation (4 papers). Joseph Eckman is often cited by papers focused on Asthma and respiratory diseases (7 papers), Allergic Rhinitis and Sensitization (4 papers) and Synthesis and Biological Evaluation (4 papers). Joseph Eckman collaborates with scholars based in United States, Belgium and Netherlands. Joseph Eckman's co-authors include Changgeng Qian, T. Y. Shen, S H Ip, Tesfaye Biftu, Ralph T. Scannell, Narshinha P. Argade, Timothy A. Lewis, Arvind A. Natu, Donna M. Wypij and Michel Gillard and has published in prestigious journals such as Blood, Cancer Research and CHEST Journal.

In The Last Decade

Joseph Eckman

19 papers receiving 370 citations

Peers

Joseph Eckman
Suzanne J. Romano United States
George Doherty United States
Eva J. van Rooden Netherlands
R. Dijkman Netherlands
Peter Ditte Slovakia
Suzanne J. Romano United States
Joseph Eckman
Citations per year, relative to Joseph Eckman Joseph Eckman (= 1×) peers Suzanne J. Romano

Countries citing papers authored by Joseph Eckman

Since Specialization
Citations

This map shows the geographic impact of Joseph Eckman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Eckman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Eckman more than expected).

Fields of papers citing papers by Joseph Eckman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Eckman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Eckman. The network helps show where Joseph Eckman may publish in the future.

Co-authorship network of co-authors of Joseph Eckman

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Eckman. A scholar is included among the top collaborators of Joseph Eckman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Eckman. Joseph Eckman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Cabal, Antonio, Khamir Mehta, David Ross, et al.. (2016). Preclinical Experimental and Mathematical Approaches for Assessing Effective Doses of Inhaled Drugs, Using Mometasone to Support Human Dose Predictions. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 29(4). 362–377. 17 indexed citations
2.
Eckman, Joseph, Hyun‐Hee Lee, M Salmon, et al.. (2014). Anti-inflammatory actions of Chemoattractant Receptor-homologous molecule expressed on Th2 by the antagonist MK-7246 in a novel rat model of Alternaria alternata elicited pulmonary inflammation. European Journal of Pharmacology. 743. 106–116. 10 indexed citations
3.
Eckman, Joseph, Robbie L. McLeod, Lily Y. Moy, et al.. (2013). Alternaria alternata induced inflammatory lung responses: a novel in vivo PK/PD model. Journal of Inflammation. 10(S1). 3 indexed citations
4.
Li, Jing, Deborah Knee, Youzhen Wang, et al.. (2008). LBY135, a novel anti‐DR5 agonistic antibody induces tumor cell–specific cytotoxic activity in human colon tumor cell lines and xenografts. Drug Development Research. 69(2). 69–82. 15 indexed citations
5.
Li, Jing, Betty Tang, Joseph Eckman, et al.. (2007). Antitumor efficacy of LBY135, an anti-DR5 monoclonal antibody, alone or in combination with chemotherapy in human colon tumor cell lines and xenografts. Cancer Research. 67. 4874–4874. 5 indexed citations
6.
Evans, Jilly F., Jeremy Kintigh, Emily Hill, et al.. (2007). Novel, Acidic CCR2 Receptor Antagonists: Lead Optimization. Letters in Drug Design & Discovery. 4(4). 263–271. 21 indexed citations
7.
Eckman, Joseph, Paul J. Higgins, Michel Gillard, et al.. (2007). Novel, Acidic CCR2 Receptor Antagonists: From Hit to Lead. Letters in Drug Design & Discovery. 4(3). 185–191. 14 indexed citations
8.
Growney, Joseph D., Peter Atadja, Wenlin Shao, et al.. (2007). Efficacy of Panobinostat (LBH589) in Multiple Myeloma Cell Lines and In Vivo Mouse Model: Tumor-Specific Cytotoxicity and Protection of Bone Integrity in Multiple Myeloma.. Blood. 110(11). 1510–1510. 3 indexed citations
9.
Lewis, Timothy A., Joseph Eckman, Michel Gillard, et al.. (2005). 5-Lipoxygenase inhibition by N-hydroxycarbamates in dual-function compounds. Bioorganic & Medicinal Chemistry Letters. 15(4). 1083–1085. 26 indexed citations
10.
Lewis, Timothy A., Joseph Eckman, James L. Ellis, et al.. (2004). 5-Lipoxygenase inhibitors with histamine H 1 receptor antagonist activity. Bioorganic & Medicinal Chemistry Letters. 14(9). 2265–2268. 27 indexed citations
11.
Lewis, Timothy A., Michelle Young, Xiong Cai, et al.. (2004). Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity. Bioorganic & Medicinal Chemistry Letters. 14(22). 5591–5594. 8 indexed citations
12.
Scannell, Ralph T., Xiong Cai, Joseph Eckman, et al.. (2004). Novel dual acting molecules possessing 5-lipoxygenase enzyme inhibition and histamine H1 receptor antagonist properties. Inflammation Research. 53(0). S33–S34. 1 indexed citations
13.
Selig, William M., Joseph Eckman, Donna M. Wypij, et al.. (2003). UCB 62045. CHEST Journal. 123(3). 371S–371S. 4 indexed citations
14.
Qian, Changgeng, et al.. (2001). Anti-inflammatory activities of LDP-392, A dual PAF receptor antagonist and 5-lipoxygenase inhibitor. Pharmacological Research. 44(3). 213–220. 11 indexed citations
15.
Argade, Narshinha P., et al.. (1999). Synthesis and screening of a combinatorial library of naphthalene substituted chalcones: inhibitors of leukotriene B41NCL Communication No. 6453.1. Bioorganic & Medicinal Chemistry. 7(6). 1237–1240. 22 indexed citations
17.
Cai, Xiong, Ralph T. Scannell, Joseph Eckman, et al.. (1995). Cmi-206: A potent dual platelet activating factor antagonist and 5-lipoxygenase inhibitor. Bioorganic & Medicinal Chemistry Letters. 5(6). 643–648. 2 indexed citations
18.
Qian, Changgeng, et al.. (1993). Epibatidine is a nicotinic analgesic. European Journal of Pharmacology. 250(3). R13–R14. 146 indexed citations
19.
Qian, Changgeng, et al.. (1993). The analgesic effect of epibatidine and isomers. Bioorganic & Medicinal Chemistry Letters. 3(12). 2759–2764. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026